Two combined photosensitizers: A goal for more effective photodynamic therapy of cancer

Cell Death and Disease

Volumn 5, Issue 3, 2014, Pages

  Acedo, P ^a   Stockert, J C ^a   Canete M ^a   Villanueva, A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Cancer; Combined strategy; Photodynamic therapy

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C; F ACTIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ZINC; PORPHYRIN MESO TETRAKIS(4 N METHYLPYRIDYL)PORPHINE; PROTEIN BAX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; MELANOMA; MICROTUBULE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TIME-LAPSE VIDEO MICROSCOPY; TUMOR LOCALIZATION;

ACTINS; ANIMALS; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG SYNERGISM; FEMALE; FOCAL ADHESION KINASE 1; HELA CELLS; HUMANS; INDOLES; INJECTIONS, INTRAVENOUS; MCF-7 CELLS; MICE; MICE, INBRED C57BL; MICROSCOPY, VIDEO; MICROTUBULES; NECROSIS; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TIME FACTORS; TIME-LAPSE IMAGING; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84897466134     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.77     Document Type: Article

References (48)

1. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011; 61: 250-281.
2. Yoo JO, Ha KS. New insights into the mechanisms for photodynamic therapy-induced cancer cell death. Int Rev Cell Mol Biol 2012; 295: 139-174.
3. Allison RR, Moghissi K. Oncologic photodynamic therapy: clinical strategies that modulate mechanisms of action. Photodiagnosis. Photodyn Ther 2013; 10: 331-341.
4. Rizvi I, Celli JP, Evans CL, Abu-Yousif AO, Muzikansky A, Pogue BW et al. Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a threedimensional model for micrometastatic ovarian cancer. Cancer Res 2010; 70: 9319-9328.
5. Wei XQ, Ma HQ, Liu AH, Zhang YZ. Synergistic anticancer activity of 5-aminolevulinic acid photodynamic therapy in combination with low-dose cisplatin on Hela cells. Asian Pac J Cancer Prev 2013; 14: 3023-3028.
6. Nakano A, Watanabe D, Akita Y, Kawamura T, Tamada Y, Matsumoto Y. Treatment efficiency of combining photodynamic therapy and ionizing radiation for Bowen's disease. J Eur Acad Dermatol Venereol 2011; 25: 475-478.
7. Torres T, Fernandes I, Costa V, Selores M. Photodynamic therapy as adjunctive therapy for morpheaform basal cell carcinoma. Acta Dermatovenerol Alp Panonica Adriat 2011; 20: 23-25.
8. Bai D, Xia X, Yow CMN, Chu ESM, Xu C. Hypocrellin B-encapsulated nanoparticlemediated rev-caspase-3 gene transfection and photodynamic therapy on tumor cells. Eur J Pharmacol 2011; 650: 496-500.
9. Kwitniewski M, Juzeniene A, Glosnicka R, Moan J. Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy? Photochem Photobiol Sci 2008; 7: 1011-1017.
10. Castano AP, Mroz P, Wu MX, Hamblin MR. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc Natl Acad Sci USA 2008; 105: 5495-5500.
11. Separovic D, Bielawski J, Pierce JS, Merchant S, Tarca AL, Bhatti G et al. Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response. Int J Oncol 2011; 38: 521-527.
12. Ferrario A, Lim S, Xu F, Luna M, Gaffney KJ, Petasis NA et al. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib. Cancer Lett 2011; 304: 33-40.
13. Paszko E, Ehrhardt C, Senge MO, Kelleher DP, Reynolds JV. Nanodrug applications in photodynamic therapy. Photodiagnosis Photodyn Ther 2011; 8: 14-29.
14. Master A, Livingston M, Gupta AS. Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J Control Release 2013; 168: 88-102.
15. Barras A, Boussekey L, Courtade E, Boukherroub R. Hypericin-loaded lipid nanocapsules for photodynamic cancer therapy in vitro. Nanoscale 2013; 5: 10562-10572.
16. Schneider-Yin X, Kurmanaviciene A, Roth M, Roos M, Fedier A, Minder E et al. Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light. Photodiagnosis Photodyn Ther 2009; 6: 12-18.
17. Villanueva A, Stockert JC, Cañete M, Acedo P. A new protocol in photodynamic therapy: enhanced tumour cell death by combining two different photosensitizers. Photochem Photobiol Sci 2010; 9: 295-297.
18. Besic Gyenge E, Lüscher D, Forny P, Antoniol M, Geisberger G, Walt H et al. Photodynamic mechanisms induced by a combination of hypericin and a chlorin basedphotosensitizer in head and neck squamous cell carcinoma cells. Photochem Photobiol 2013; 89: 150-162.
19. Villanueva A, Vidania R, Stockert JC, Cañete M, Juarranz A. Photodynamic effects on cultured tumor cells. Cytoskeleton alterations and cell death mechanisms. In: Nalwa HS (eds) Handbook of Photochemistry and Photobiology Los AngelesAmerican Scientific Publishers, 2003. pp 1-39.
20. Wu L, Yang L, Huang J, Zhang L, Weng X, Zhang X et al. Cationic ester porphyrins cause high levels of phototoxicity in tumor cells and induction of apoptosis in HeLa cells. Chem Biodivers 2009; 6: 1066-1076.
21. Abdelghany SM, Schmid D, Deacon J, Jaworski J, Fay F, McLaughlin KM et al. Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4- pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticles. Biomacromolecules 2013; 14: 302-310.
22. Cristobal J, Stockert JC, Villanueva A, Rello-Varona S, Juarranz A, Cañ ete M. Caspase-2: a possible trigger of apoptosis induced in A-549 tumor cells by ZnPc photodynamic treatment. Int J Oncol 2006; 28: 1057-1063.
23. Rello-Varona S, Stockert JC, Cañ ete M, Acedo P, Villanueva A. Mitotic catastrophe induced in HeLa cells by photodynamic treatment with Zn(II)-phthalocyanine. Int J Oncol 2008; 32: 1189-1196.
24. Lau JTF, Lo PC, Fong WP, Ng DKP. A Zinc(II) phthalocyanine conjugated with an oxaliplatin derivative for dual chemo- and photodynamic therapy. J Med Chem 2012; 55: 5446-5454.
25. Valeriote F, Lin H. Synergistic interaction of anticancer agents: a cellular perspective. Cancer Chemother Rep 1975; 59: 895-900.
26. Rello S, Stockert JC, Moreno V, Gamez A, Pacheco M, Juarranz A et al. Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis 2005; 10: 201-208.
27. Ke MS, Xue L, Feyes DK, Azizuddin K, Baron ED, McCormick TS et al. Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4. Photochem Photobiol 2008; 84: 407-414.
28. Berlanda J, Kiesslich T, Engelhardt V, Krammer B, Plaetzer K. Comparative in vitro study on the characteristics of different photosensitizers employed in PDT. J Photochem Photobiol B 2010; 100: 173-180.
29. Sasnouski S, Pic E, Dumas D, Zorin V, D'Hallewin M, Guillemin F et al. Influence of incubation time and sensitizer localization on meta-tetra (hydroxyphenyl) chlorin (mTHPC)-induced photoinactivation of cells. Radiat Res 2007; 168: 209-217.
30. Villanueva A, Domínguez V, Polo S, Vendrell V, Sanz C, Cañ ete T et al. Photokilling mechanisms induced by zinc(II)-phthalocyanine on cultured tumor cells. Oncol Res 1999; 11: 447-453.
31. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 2009; 16: 1093-1107.
32. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-120.
33. Mroz P, Yaroslavsky A, Kharkwal GB, Hamblin MR. Cell Death Pathways in Photodynamic Therapy of Cancer. Cancers 2011; 3: 2516-2539.
34. Ruiz-Gonzalez R, Acedo P, Sanchez-Garcia D, Nonell S, Cañ ete M, Stockert JC et al. Efficient induction of apoptosis in HeLa cells by a novel cationic porphycene photosensitizer. Eur J Med Chem 2013; 63: 401-414.
35. Nicotera P, Melino G. Regulation of the apoptosis-necrosis switch. Oncogene 2004; 23: 2757-2765.
36. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. Photodiagnosis Photodyn Ther 2005; 2: 1-23.
37. Zamzami N, Kroemer G. Methods to measure membrane potential and permeability transition in the mitochondria during apoptosis. Methods Mol Biol 2004; 282: 103-115.
38. Plaetzer K, Krammer B, Berlanda J, Berr F, Kiesslich T. Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers Med Sci 2009; 24: 259-268.
39. Česen MH, Pegan K, Spes A, Turk B. Lysosomal pathways to cell death and their therapeutic applications. Exp Cell Res 2012; 318: 1245-1251.
40. Repnik U, Stoka V, Turk V, Turk B. Lysosomes and lysosomal cathepsins in cell death. Biochim Biophys Acta 2012; 1824: 22-33.
41. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; 9: 231-241.
42. Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta 2013; 1833: 3481-3498.
43. Golubovskaya VM. Focal adhesion kinase as a cancer therapy target. Anticancer Agents Med Chem 2010; 10: 735-741.
44. Zheng Y, Lu Z. Paradoxical roles of FAK in tumor cell migration and metastasis. Cell Cycle 2009; 8: 3474-3479.
45. Yang TH, Chen CT, Wang CP, Lou PJ. Photodynamic therapy suppresses the migration and invasion of head and neck cancer cells in vitro. Oral Oncol 2007; 43: 358-365.
46. Mian MF, Kang C, Lee S, Choi JH, Bae SS, Kim SH et al. Cleavage of focal adhesion kinase is an early marker and modulator of oxidative stress-induced apoptosis. Chem Biol Interact 2008; 171: 57-66.
47. Chatzizacharias NA, Kouraklis GP, Theocharis SE. Disruption of FAK signaling: a side mechanism in cytotoxicity. Toxicology 2008; 245: 1-10.
48. Milla LN, Cogno IS, Rodriguez ME, Sanz-Rodriguez F, Zamarron A, Gilaberte Y et al. Isolation and characterization of squamous carcinoma cells resistant to photodynamic therapy. J Cell Biochem 2011; 112: 2266-2278.